These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15494494)

  • 41. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD137 in chronic graft-versus-host disease.
    Kim J; Cho HR; Kwon B
    Methods Mol Biol; 2014; 1155():95-108. PubMed ID: 24788176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
    Miconnet I; de La Selle V; Bruley-Rosset M
    Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
    Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
    Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
    Zhang C; Todorov I; Zhang Z; Liu Y; Kandeel F; Forman S; Strober S; Zeng D
    Blood; 2006 Apr; 107(7):2993-3001. PubMed ID: 16352808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1996 May; 17(5):789-92. PubMed ID: 8733699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S
    J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
    J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
    Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK
    Blood; 2007 May; 109(10):4548-56. PubMed ID: 17289817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Newborn blood used as a source of donor cells in a murine model of transplantation across non-MHC antigens.
    de la Selle V; Bruley-Rosset M
    Ann N Y Acad Sci; 1995 Dec; 770():351-60. PubMed ID: 8597373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction.
    Yu XZ; Bidwell S; Martin PJ; Anasetti C
    J Immunol; 1999 Nov; 163(9):4780-7. PubMed ID: 10528177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.
    Tschetter JR; Mozes E; Shearer GM
    J Immunol; 2000 Nov; 165(10):5987-94. PubMed ID: 11067962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
    Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
    J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.
    Rosset MB; Tieng V; Charron D; Toubert A
    Clin Exp Immunol; 2003 Apr; 132(1):46-52. PubMed ID: 12653835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.